Sumitomo Life Insurance Co. Trims Stake in Synopsys, Inc. $SNPS

Sumitomo Life Insurance Co. cut its stake in Synopsys, Inc. (NASDAQ:SNPS) by 19.5% in the third quarter, HoldingsChannel reports. The fund owned 6,715 shares of the semiconductor company’s stock after selling 1,622 shares during the period. Sumitomo Life Insurance Co.’s holdings in Synopsys were worth $3,313,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also bought and sold shares of SNPS. Alpine Bank Wealth Management lifted its stake in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. increased its holdings in Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after buying an additional 50 shares in the last quarter. Millstone Evans Group LLC acquired a new position in shares of Synopsys in the third quarter worth about $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys during the 3rd quarter valued at about $28,000. Finally, McIlrath & Eck LLC purchased a new position in shares of Synopsys in the 3rd quarter valued at about $29,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 results beat consensus — revenue jumped ~65.6% YoY to $2.409B and non‑GAAP EPS of $3.77 topped estimates; company reiterates full‑year revenue midpoint and provided robust FY and Q2 EPS ranges. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Board authorized a replenishment of the repurchase program (up to $2.0B), supporting shareholder returns and offsetting some integration anxieties. Synopsys Posts Financial Results for First Quarter Fiscal Year 2026
• Positive Sentiment: Some analysts remain constructive — Morgan Stanley maintained a Buy and analysts call out solid earnings quality and IP trajectory as catalysts. Synopsys: Strong Earnings Quality … Support Buy Rating
• Neutral Sentiment: Notable option activity — unusually large call buying suggests elevated speculative interest/positioning into or after the print (could magnify intraday moves).
• Negative Sentiment: Guidance and China exposure concerns: Reuters reports Synopsys flagged a more muted near‑term outlook tied to China export restrictions and macro uncertainty, which pressured the stock despite the beat. Synopsys forecasts muted quarter on China export restrictions, shares fall
• Negative Sentiment: Debt & integration risk from the large acquisition remains in focus — coverage highlights ~$13.5B in debt and questions about digesting the multibillion acquisition, keeping some investors cautious. Synopsys Carries $13.5 Billion in Debt Into Its Most Consequential Earnings Yet
• Negative Sentiment: Market reaction: several reports note SNPS “slid” despite the beat — investors appear to be weighing forward risks (China, deal debt/integration) more heavily than the quarter’s upside. Synopsys slides despite Q1 results demonstrating 65% revenue surge

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Piper Sandler cut shares of Synopsys from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $602.00 to $520.00 in a research note on Tuesday, January 13th. Citigroup assumed coverage on shares of Synopsys in a report on Monday, November 24th. They issued a “buy” rating and a $580.00 price target for the company. KeyCorp increased their price objective on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Synopsys currently has a consensus rating of “Hold” and an average price target of $547.00.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $449.17 on Thursday. The firm has a 50-day simple moving average of $472.85 and a 200-day simple moving average of $479.02. The stock has a market capitalization of $86.04 billion, a price-to-earnings ratio of 56.22, a price-to-earnings-growth ratio of 3.67 and a beta of 1.12. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s quarterly revenue was up 65.6% on a year-over-year basis. During the same period in the previous year, the business posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Janet Lee sold 250 shares of the firm’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is currently owned by company insiders.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.